UK markets open in 3 hours 16 minutes

Northwest Biotherapeutics, Inc. (NWBO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.4600-0.0050 (-1.08%)
At close: 03:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,932
1,932
1,683
1,005
1,291
Operating expenses
Research development
27,730
27,730
35,511
20,308
33,637
Selling general and administrative
29,710
29,710
33,353
33,399
54,259
Total operating expenses
57,440
57,440
68,864
53,707
87,896
Operating income or loss
-55,508
-55,508
-67,181
-52,702
-86,605
Interest expense
5,241
5,241
6,068
5,011
8,544
Total other income/expenses net
-1,850
-1,850
-31,783
236,839
-434,672
Income before tax
-62,599
-62,599
-105,032
179,126
-529,821
Income from continuing operations
-62,599
-62,599
-105,032
179,126
-529,821
Net income
-62,599
-62,599
-105,032
179,126
-529,821
Net income available to common shareholders
-64,373
-64,373
-105,032
179,126
-529,821
Basic EPS
-0.06
-0.06
-0.10
0.21
-0.73
Diluted EPS
-0.06
-0.06
-0.10
-0.06
-0.73
Basic average shares
1,094,158
1,119,191
1,015,852
873,517
725,129
Diluted average shares
1,094,158
1,119,191
1,015,852
1,007,869
725,129